High prevalence of somatic PIK3CA and TP53 pathogenic variants in the normal mammary gland tissue of sporadic breast cancer patients revealed by duplex sequencing.
Anna KosteckaTomasz NowikiewiczPaweł OlszewskiMagdalena KoczkowskaMonika HorbaczMonika HeinzlMaria AndreouRenato SalazarTheresa MairPiotr MadaneckiMagdalena GucwaHanna DaviesJarosław SkokowskiPatrick G BuckleyRafał PęksaEwa ŚrutekŁukasz SzylbergJohan HartmanMichał JankowskiWojciech ZegarskiIrene Tiemann-BoegeJan P DumanskiArkadiusz PiotrowskiPublished in: NPJ breast cancer (2022)
The mammary gland undergoes hormonally stimulated cycles of proliferation, lactation, and involution. We hypothesized that these factors increase the mutational burden in glandular tissue and may explain high cancer incidence rate in the general population, and recurrent disease. Hence, we investigated the DNA sequence variants in the normal mammary gland, tumor, and peripheral blood from 52 reportedly sporadic breast cancer patients. Targeted resequencing of 542 cancer-associated genes revealed subclonal somatic pathogenic variants of: PIK3CA, TP53, AKT1, MAP3K1, CDH1, RB1, NCOR1, MED12, CBFB, TBX3, and TSHR in the normal mammary gland at considerable allelic frequencies (9 × 10 -2 - 5.2 × 10 - 1 ), indicating clonal expansion. Further evaluation of the frequently damaged PIK3CA and TP53 genes by ultra-sensitive duplex sequencing demonstrated a diversified picture of multiple low-level subclonal (in 10 -2 -10 -4 alleles) hotspot pathogenic variants. Our results raise a question about the oncogenic potential in non-tumorous mammary gland tissue of breast-conserving surgery patients.
Keyphrases
- copy number
- genome wide
- peripheral blood
- single cell
- end stage renal disease
- signaling pathway
- late onset
- risk factors
- ejection fraction
- minimally invasive
- dna methylation
- chronic kidney disease
- transcription factor
- prognostic factors
- newly diagnosed
- protein kinase
- cell proliferation
- neoadjuvant chemotherapy
- radiation therapy
- gene expression
- cancer therapy
- squamous cell carcinoma
- genome wide identification
- single molecule
- lymph node
- drug delivery
- mass spectrometry
- dairy cows
- young adults
- patient reported outcomes
- coronary artery disease
- locally advanced